Topic: continuous glucose monitor
Abbott teamed up with Omada Health to offer its FreeStyle Libre CGM system through the latter’s digital care program for type 2 diabetes.
The collaboration is similar to a contemporaneously announced move from the two companies’ competitors, Abbott and Sanofi.
Abbott and Sanofi are partnering up to develop tools that connect their respective blood sugar tracking and insulin delivery technologies.
Medtronic teamed with Tidepool for an interoperable version of its MiniMed pump and will help Tidepool secure the FDA’s OK for its app in return.
Abbott found that the system was able to significantly reduce hemoglobin A1c levels among patients who take multiple insulin injections per day.
The FDA warned diabetes patients of the risks of using homegrown treatment devices, such as unrecognized combos of CGMs and insulin pumps.
Good for up to 90 days, Senseonics’ Eversense CGM comes paired with a mobile app that can notify adults with diabetes if their blood sugar levels go too high or dip too low.
Biolinq tacked on an extra $4.75 million to its series A total to fund development of its coin-sized sensor patch for monitoring glucose levels.
Former Medtronic Diabetes chief medical officer Francine Kaufman has joined continuous glucose monitor developer Senseonics as its new CMO.
Glooko’s mobile app is now free for any person with diabetes, with the company ditching subscription fees for unsponsored users.